Christopher Lech is a seasoned strategy consultant with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Director at IQVIA since October 2016, Christopher leads project teams and delivers strategic engagements throughout the drug development lifecycle across North America, Europe, and Asia-Pacific. Prior to this role, Christopher held various positions at Nanyang Technological University from August 2009 to October 2016, including Postdoctoral Research Fellow, where efforts focused on commercializing DNA-based therapeutics and leading research initiatives that resulted in multiple scientific publications and patents. Christopher earned a Ph.D. in Biophysics from Nanyang Technological University and a B.S. in Engineering Physics from Embry-Riddle Aeronautical University.
This person is not in any teams
This person is not in any offices